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A B S T R A C T
Background
Low-back pain (LBP) and related disabilities are major public health problems and a major cause of medical expenses, absenteeism and
disablement. Low level laser therapy (LLLT) can be used as a therapeutic intervention for musculoskeletal disorders such as back pain.
Objectives
To assess the effects of LLLT in patients with non-specific low-back pain and to explore the most effective method of administering
LLLT for this disorder.
Search strategy
We searched CENTRAL (The Cochrane Library 2005, Issue 2), MEDLINE and CINAHL from their start to January 2007 and
EMBASE, AMED and PEDro from their start to 2005 with no language restrictions. We screened references in the included studies
and in reviews of the literature and conducted citation tracking of identified RCTs and reviews using Science Citation Index. We also
contacted content experts.
Selection criteria
Only randomised controlled clinical trials (RCTs) investigating low level laser therapy as a light source treatment for non-specific low-
back pain were included.
Data collection and analysis
Two authors independently assessed methodological quality using the criteria recommended by the Cochrane Back Review Group and
extracted data. Consensus was used to resolve disagreements. Clinically and statistically homogeneous studies were pooled using the
fixed-effect model; clinically homogeneous and statistically heterogeneous studies were pooled using the random-effects model.
Main results
Six RCTs with reasonable quality were included in the review. All of them were published in English. There is some evidence of pain
relief with LLLT, compared to sham therapy for subacute and chronic low-back pain. These effects were only observed at short-term
and intermediate-term follow-ups. Long-term follow-ups were not reported. There was no difference between LLLT and comparison
groups for pain-related disability.
There is insufficient evidence to determine the effectiveness of LLLT on antero-posterior lumbar range of motion compared to control
group in short-term follow-up. The relapse rate in the LLLT group was significantly lower than in the control group at six months
follow-up period according to the findings of two trials.
Authors’ conclusions
No side effects were reported. However, we conclude that there are insufficient data to draw firm conclusions.
There is a need for further methodologically rigorous RCTs to evaluate the effects of LLLT compared to other treatments, different
lengths of treatment, different wavelengths and different dosages. Comparison of different LLLT treatments will be more reasonable if
dose calculation methods are harmonized.
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P L A I N L A N G U A G E S U M M A R Y
Low level laser therapy for low-back pain
Sixty to eighty per cent of people suffer from back pain at some time in their lives. Of those who develop acute low-back pain (LBP),
up to 30% will go on to develop chronic LBP. The toll on individuals, families and society makes the successful management of this
common, but benign condition an important goal.
Low level laser therapy (LLLT) is a therapeutic intervention for back pain that is used by some physiotherapists. Low level laser therapy
is a non-invasive light source treatment that generates a single wavelength of light. It emits no heat, sound, or vibration. It is also
referred to as photobiology or biostimulation. LLLT is believed to affect the function of connective tissue cells (fibroblasts), accelerate
connective tissue repair and act as an anti-inflammatory agent. Lasers with different wavelengths, varying from 632 to 904 nm, are
used in the treatment of musculoskeletal disorders.
We included six small studies with a total of 318 people with non-specific low-back pain of varying durations. Three of the studies
(126 people) showed that, on average, LLLT was more effective at reducing pain in the short-term (less than three months) than sham
(fake) laser. However, the strength and number of treatment were varied and the amount of the pain reduction was small. Two other
studies (112 people) showed that, on average, LLLT was more effective at reducing pain in the intermediate-term (six months) than
sham laser. The treatment doses were similar in these two studies, but the population and number of treatments were different.
Three studies (126 people) showed that, on average, LLLT was no more effective at reducing disability in the short-term than sham
laser. Once again, strength and number of treatment doses and populations were varied. Another trial (120 people) showed a reduction
in pain, disability and analgesic use for the two groups who received a series of LLLT treatments compared to the group who received
sham laser.
Based on these small trials, there are insufficient data to either support or refute the effectiveness of LLLT for the treatment of LBP.
We had hoped to answer the questions of optimal dose, application techniques or length of treatment, but were unable to with the
available evidence. There were also no trials comparing LLLT to other treatments for low-back pain. Further trials are required that are
larger and look specifically at these questions.
B A C K G R O U N D
Low-back pain (LBP) and related disabilities are major public
health problems and major causes of medical expenses, absen-
teeism and disablement (van Tulder 1995). Sixty to eighty per cent
of people suffer from back pain at some time in their lives (An-
dersson 1997; Waddell 2004). Of all adults complaining of back
pain, only about five per cent can be classified as having nerve root
pain (using strict diagnostic criteria), with the remainder having
back pain with or without referred leg pain, which is commonly
referred to as non-specific low-back pain (Waddell 2004).Of those
who develop acute LBP, up to 30% will go on to develop chronic
LBP. The past 15 years have seen an intensive research effort to
identify effective treatments and management strategies for low-
back pain (Nachemson 2000).
Acute non-specific LBP is a benign and self-limiting condition.
Once serious pathology (red flags) has been ruled out, current
guidelines for the management of acute back pain recommend
painmanagement interventions plus reassurance and advice to stay
active as the interventions of choice (Waddell 2004). The aim of
conservative (non-surgical) treatments for LBP is usually to relieve
pain and associated disability. Recommended treatment options
are diverse but there is sound evidence for only a minority of these
therapies (CRD 2000; Nachemson 2000).
Low level laser therapy (LLLT) is currently used by some phys-
iotherapists as a therapeutic intervention for musculoskeletal dis-
orders such as back pain (Beckerman 1992; Bjordal 2003). Low
level laser therapy is a light source treatment that generates light of
a single wavelength. It emits no heat, sound, or vibration. Instead
of producing a thermal effect, LLLT may act by non-thermal or
photochemical reactions in cells. It is also referred to as photobi-
ology or biostimulation (Basford 1989; Baxter 1991). Low level
laser therapy is thought to affect fibroblast function and accelerate
connective tissue repair (Kreisler 2002). It has also been reported
that LLLT has anti-inflammatory effects due to its action in reduc-
ing prostaglandin synthesis (Sakurai 2000). Most LLLT lasers are
Class 3a or Class 3b (Baxter 1991). Class 3a LLLTs have a power
output of less than 5 mW, and Class 3b LLLTs have an output
of less than 500 mW. Low level laser therapy lasers can be either
visible or invisible.
Some studies suggest that LLLT has a beneficial anti-inflamma-
tory and pain attenuation effect in humans (Ceccherelli 1989; Mi-
zokami 1993). Research in humans on wound healing and anti-
inflammatory effects of LLLT showed conflicting results (Baxter
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1991). The effectiveness of laser therapy in painful disorders is still
unclear and needs to be examined more rigorously (Beckerman
1992).
O B J E C T I V E S
1) To assess the effectiveness of LLLT for the treatment of non-
specific low-back pain.
2) To explore the most effective method of administering LLLT
for non-specific low-back pain, including the optimal:
• dosage
• application techniques
• length of treatment
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Published reports of completed randomised controlled trials
(RCTs) were included. There were no restrictions on the basis of
language or date of trial.
Types of participants
Trials that includedmale or female subjects aged 18 years and over,
with acute (pain for four weeks or less), subacute (pain for one
to three months) or chronic low-back pain (pain for more than
three months) were included (van Tulder 2003). Low-back pain
was defined as pain localised between the shoulder blades and the
folds of the buttocks, with or without radiation to the legs (CRD
2000).
Trials that included subjects with low-back pain caused by specific
pathological entities such as infection, metastatic diseases, neo-
plasms, osteoporosis, rheumatoid arthritis, fracture, inflammatory
processes or radicular syndrome were excluded.
Trials that discussed musculoskeletal disorders were included if a
separate analysis was reported for low-back pain.
Types of intervention
Low level laser therapy (LLLT) is a light source that generates
pure light, of a single wavelength with non-thermal effects (Baxter
1991). We included reports of studies that explored the effects of
all types of LLLT (Classes I, II, and III), including all wavelengths,
compared to another treatment. The comparison interventions
were no treatment, sham procedures or other therapeutic inter-
ventions.
Types of outcome measures
We chose outcomes for this review based on those recommended
by the Cochrane Back Review Group (Deyo 1998). The primary
outcomes were:
• Low-back pain measured by visual analogue scale (Huskisson
1974), box scale (Jensen 1989), McGill Pain Questionnaire
(Melzack 1987) or other validated quantitative measures.
• Low-back-related disabilitymeasured by theOswestry disability
questionnaire (Fairbank 1980), Roland-Morris disability scale
(Patrick 1995; Roland 1983) or other validated quantitative
measures.
Secondary outcomes were:
• Overall improvement or satisfaction with treatment as rated by
either participants or therapists.
• Health-related quality of life asmeasured by questionnaires such
as the SF-12 (Ware 1996), SF-36 (Ware 1992), or EuroQoL
(EuroQoL 1990).
• Return-to-work, days of absenteeism, or days of reduced activ-
ities (Deyo 1998).
• Physical examination: measuring range of motion, spinal flexi-
bility, or muscle strength.
• Side effects, adverse effects, medication use and health care use.
To be eligible for this review, studies had to have measured at least
one of the outcomes.
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Cochrane Back Group methods used in reviews.
Relevant studies meeting the inclusion criteria were identified by:
• A computer-aided search of CENTRAL (The Cochrane
Library 2005, issue 2), MEDLINE (1966 to January
2007), EMBASE (1988 to March 2005), CINAHL
(1982 to January 2007), AMED (the Allied and
Complementary Medicine Database, 1985 to March
2005) and PEDro- the physiotherapy evidence database
(http://www.pedro.fhs.usyd.edu.au/index.html) (to March
2005)
• Screening references given in relevant reviews and identified
RCTs.
• Citation tracking of identified RCTs and reviews using Science
Citation Index
• Communication with Managing Editor, Back Review Group
for additional RCTs.
• Personal contact with content experts.
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The search strategy in Additional Table 1 (Table 01) was used for
MEDLINE(OVID) and CINAHL(OVID), based on van Tulder
2003.
For EMBASE, the search strategy suggested by the Back Review
Group (van Tulder 2003) was used. Search words used for the
PEDro database were: low back pain, back pain, backache,
lumbar, dorsalgia, lumbago, laser, infrared, effectiveness,
treatment, therapy. A similar process was used for AMED.
M E T H O D S O F T H E R E V I E W
Selecting trials for inclusion:
All the citations identified by the above searches were downloaded
into a reference manager database. Two authors with expertise
in medicine, physiotherapy, laser therapy and research methods
(ES and RYN), non-blinded to authors and publication journals,
independently screened for inclusion, using the pre-specified
criteria. If it was clear from the abstract that the study did not
meet the selection criteria, it was excluded. If it was unclear from
the abstract whether the study met the selection criteria, the full
paper was retrieved. Two authors (MAK and SAMH), using the
same selection criteria used for the abstract screening, read the full
paper and made final selection decisions. Any discrepancies were
resolved by discussion, followed, if necessary, by a third reviewer
(RYN) if disagreement persisted.
For studies that were excluded following review of the full text,
reasons for exclusion were detailed in the table of Characteristics
of Excluded Studies, with a summary provided in the text of the
review.
Assessment of Methodological Quality:
Two reviewers (MAK and SI) independently assessed the
methodological quality of each RCT. Disagreements were dealt
with by discussion and consensus in review team (ES, AR and
RYN).
The 11 criteria recommended by the Back Review Group were
used to assess the methodological quality of the RCTs (van Tulder
2003). Each criterion was scored as “yes”,“ no” or “unclear”,
depending on how successfully the criterion was met. The criteria
for evaluating the internal validity and their operationalization are
found in Additional Table 02.
If the study provided “unclear” information on methodological
criteria, the authors were contacted for additional information. If
no response was obtained from authors or if the information was
no longer available, these criteria remained ’unclear’.
We had planned a sensitivity analysis to determine whether
the overall results were the same when studies above different
methodological cut-off points were synthesized (vanTulder 2003),
but were unable to because of lack of studies.
Data extraction:
Two reviewers (MAK and SI) independently extracted the data
on study design, participants, interventions and outcomes. Data
extraction was not blinded to authors and journal of publication.
Data were extracted and entered into Review Manager 4.2 for the
calculation of summary statistics. Disagreements on the results
of data extraction were resolved by consensus. If disagreement
persisted, a third reviewer (RYN) was consulted.
Laser characteristics and dosages were recalculated based on the
data available in the articles or from personal contacts. The
WorldAssociation of LaserTherapy acknowledges that incomplete
dosage reporting is a major problem, and recommends that review
authors recalculate laser dosages of primary studies (WALT-a
2005). We calculated power, density (mW/cm2) and dose (J)
for each study. Power density for pulse lasers (mW/cm2) was
calculated by multiplying the peak power pulse by the pulse
duration and then by the pulse frequency and dividing the
total by the spot size on the skin. Power density for lasers with
continuous output (mW/cm2) was calculated by dividing the
mean power by the spot size on the skin. Dose (J) was calculated
by multiplying the mean power by the treatment time per
session. Authors were contacted to provide sufficient information
for recalculation. Based on the recommended anti-inflammatory
dosage for low level laser therapy developed by theWALT (WALT-
b 2005), the minimum dose for irradiating 904 nm lasers to the
lumbar spine is 4 J per point. Recommended doses are based
on ultrasonographic measurements of depths from skin surface
and typical volume of pathological tissue and estimated optical
penetration for the different laser types in Caucasians. According
to these recommendations, included articles were divided into
adequate and inadequate dosing subgroups (see Table 04).
Analysis:
The statistical analysis followed the recommendations of the
Cochrane Handbook (CCHandbook 2005) and the Back Review
Group (van Tulder 2003). The results of each RCT were
plotted as point estimates with corresponding 95% confidence
intervals (95% CI). Potential sources of clinical heterogeneity
were identified. For studies judged as clinically homogeneous,
statistical heterogeneity was tested by the Q test (chi-square) and
I2. Clinically and statistically homogeneous studies were pooled
using the fixed effectmodel. If datawere statistically heterogeneous
(P < 0.1), reasons for heterogeneity were explored. Regardless
of any evidence of statistical heterogeneity, the influence of
specific differences between the RCTs was investigated. Clinically
homogeneous and statistically heterogeneous studies were pooled
using the random effects model. Standardized mean differences
(SMD), or weighted mean differences (WMD) with 95% CI
were calculated for each outcome. Because pain, quality of life
or functional status were measured with similar but not identical
instruments, SMD instead of WMD were calculated. We selected
a 20-mm change in pain on a 100-point pain scale, or 30% as
the minimum clinically significant difference (MCID) for pain
scores, based on Farrar 2001, who suggests an absolute difference
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of two points on 0 to 10 numeric scale and other studies that
suggest that the minimum clinically significant change is not an
absolute number but a range, that depends on the baseline values
and duration of pain (van der Roer 2006).
To create a pooled effect measure, the team examined possible
sources of clinical heterogeneity by considering:
• methodological study quality;
• population differences in age, gender;
• duration of symptoms (i.e. acute versus chronic);
• low-back pain aetiology;
• intervention type by laser class, treatment protocol, treatment
duration and irradiation sites;
• outcomes [i.e. subject reports of pain and pain relief, range of
motion, other measures of performance (i.e. activities of daily
living, disability, function), or employment status].
Outcomes were presented separately for less than three months
after randomisation (short-term follow-up), between threemonths
and one year (intermediate follow-up), or longer than one year
(long term follow-up). Subgroup analysis was performed for
adequate and inadequate laser dosing according to power density
and irradiated energy.
Sub-group analyses were planned for acute, sub-acute or chronic
low-back pain, but because of insufficient number of studies were
not carried out. Similarly, sensitivity analysis, meta-regression and
publication bias tests were planned but not carried out because of
insufficient numbers of studies.
When the data could not be entered in the meta-analysis because
of the way the authors of the trials reported the results (for
example: no information about standard deviation of the means)
we performed a qualitative analysis by attributing levels of evidence
to the effectiveness of low level laser therapy, taking into account
themethodological quality and the outcome of the original studies
(van Tulder 2003):
• Strong evidence* - consistent** findings among multiple
higher quality RCTs
• Moderate evidence - consistent findings among multiple lower
quality RCTs and/or one higher quality RCT
• Limited evidence - one lower quality RCT
• Conflicting evidence - inconsistent findings among multiple
trials (RCTs)
• No evidence - no RCTs
* There is consensus among the Editorial Board of the BackReview
Group that strong evidence can only be provided by multiple
higher quality trials that replicate findings of other researchers in
other settings.
** When more than 75% of the trials report the same findings.
D E S C R I P T I O N O F S T U D I E S
In total, we found six small trials (318 people) that met the inclu-
sion criteria.
The populations included in the trials had a diagnosis of non-
specific LBP, but differed with respect to duration of pain, previ-
ous treatments and distributions of age. One study (Longo 1991)
was limited to patients with acute pain but the duration was not
clear in the report and some patients might have suffered from
an acute exacerbation of chronic low-back pain. Another trial in-
cluded patients with LBP of at least one-month duration (Basford
1999), but the mean duration of pain in the laser and control
groups was seven and 13 months respectively. In another study
(Soriano 1998), patients over the age of 60 with LBP of at least
three months were included. Two other trials (Gur 2003; Klein
1990) were limited to patients with chronic pain (more than one
year). Toya 1994 had no limitations for the duration of pain. The
lumbar pain group (41 patients) in this study consisted of lum-
bago (23), ischiatic neuralgia (9), lumbar musculofascial pain (2),
herniated disc (3), lumbar spondylosis (4).
The types of laser, dose, duration and frequency of treatments var-
ied among the studies. Five studies(Gur 2003; Klein 1990; Longo
1991; Soriano 1998; Toya 1994) used infrared diode lasers. Only
one study used a 1060 nm Nd-Yag laser (Basford 1999). Irradia-
tion energy densities were recalculated based on the information
provided in the reports and if possible, directly from authors. Laser
doses ranged from 0.1 J (Klein 1990) to 48.8 J (Basford 1999).
Only three studies (Basford 1999; Soriano 1998; Toya 1994) used
sufficient laser dosage according to WALT-b 2005 recommenda-
tions (Table 04). Basford 1999 used a Nd-Yag laser with some
thermal effects. This study was included because the laser dose
was sufficient based onWALT recommendations and the laser was
considered low level laser by the authors.
In three studies (Longo 1991; Soriano 1998; Toya 1994), treat-
ment duration was less than two weeks; in others it was about
four weeks. The number of treatment sessions differed from one
session in Toya 1994 to 20 sessions in Gur 2003. All studies irra-
diated painful areas, except Longo 1991, in which the laser targets
were painful areas and trigger points. In two studies (Gur 2003;
Klein 1990), exercise therapy was used in both the laser and con-
trol groups similarly. The exercise programs in these studies were
considered to be comparable.
With respect to the outcome measures, pain intensity was used in
all except one study (Longo 1991), and measured with a visual
analogue scale (VAS) on a 0 to 100 scale. Three studies (Basford
1999; Gur 2003; Klein 1990) assessed disability using validated
questionnaires and lumbar range of motion. Pain relapse rate was
measured in two studies (Longo 1991; Soriano 1998). Only one
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study reported self-rated overall improvement (Longo 1991). The
timing of outcome measures varied from “immediately after the
end of sessions” to one year after randomisation.
Details about each included trial are given in the table of Charac-
teristics of included studies.
M E T H O D O L O G I C A L Q U A L I T Y
The results of the methodological quality assessment are shown in
Table 03. All studies were described as randomised; however the
method of randomisation was explicit in only three studies (Bas-
ford 1999; Klein 1990; Toya 1994). One study (Basford 1999)
used a block randomisation method for patient allocation. We re-
mained unsure about the effectiveness of the randomisation in this
study because there was a big difference in the duration of pain
between the two groups (seven months in the laser group and 13
months in the control group). Allocation to treatment groups was
concealed in two studies (Klein 1990; Toya 1994). Patients and
care providers were blinded in all studies except one (Gur 2003).
Outcome assessors were blinded in five trials (Basford 1999; Gur
2003; Klein 1990; Longo 1991; Toya 1994). The drop-out rate
and loss to follow-up in the data analysed were less than 20% in all
studies but one (Soriano 1998), where 21% were excluded from
final analysis in the control arm, while there were only 11% ex-
cluded from the experimental group. Two studies conducted an in-
tention-to-treat analysis (Gur 2003; Klein 1990). For more details
about the criteria met in each trial, see Table 02. The quality scores
of the included studies according to the criteria recommended by
the Back Review Group’s method guidelines (van Tulder 2003)
ranged from six to 11.
R E S U L T S
Study selection:
Our searches resulted in the identification of 59 reports in MED-
LINE, 107 in EMBASE, 35 in CINAHL, 9 in AMED, 577 in
PEDro and 28 in CENTRAL. After removing duplicates, 142 re-
ports were screened in the next step. After exclusion of irrelevant
trials, we obtained hard copies of 34 trials, including 25 English,
3 German, 2 Russian, 2 Polish, one Japanese and one Italian. Of
these, 24were primary studies, but only five trialsmet the inclusion
criteria. Reasons for the exclusion of these studies are explained
in the table of Characteristics of Excluded Studies. We contacted
the primary authors of trials and experts in the field of LLLT to
obtain additional information that was not reported in the pub-
lished studies. One expert informally discussed this review with
some other experts in the field of LLLT. One article was found in
this phase (Longo 1991). When we updated the literature search
to January 2007, two more potential references were located. One
was excluded; the other is listed under ’Studies awaiting assess-
ment’, pending the receipt of additional information from the au-
thor and will be addressed in the update of this review.
LLLT versus sham treatment
Pain:
The pooled analysis of three trials (n = 126) showed that LLLT was
more effective than sham for patients with chronic low-back pain
without neurologic symptoms for reducing pain (short-term fol-
low-up) with aWMD -11.33, (95% CI: -16.91 to -5.75) (Basford
1999; Gur 2003; Klein 1990). All three studies used a 100-point
VAS to measure the pain. There was no significant heterogene-
ity for comparison of pain, indicating that the difference between
LLLT and control groups was consistent across trials.
One study (Basford 1999) used adequate laser dosing and two
studies (Gur 2003; Klein 1990) used inadequate laser dosages.
The WMDs of pain at short-term follow-up were -16 (95% CI: -
27.95 to -4.05) and -10.03 (95%CI: -16.34 to -3.72) for adequate
and inadequate subgroups respectively. The same results were seen
when the studies with exercise therapy as a co-intervention in both
study arms (Gur 2003; Klein 1990) were compared with the study
without exercise therapy (Basford 1999).
One study (Soriano 1998) measured pain with a visual analogue
scale but reported the results as the percentage of pain relief graded
as poor, regular, good and excellent. In this study, at the six month
follow-up, 44.7% of the patients in the LLLT group and 15.2% of
the control group reported excellent relief (P < 0.01). In another
study (Toya 1994), pain was graded as exacerbation, little or no
change, fair, good, and excellent. The sum of the frequencies of
patients with ’excellent’, ’good’ and ’fair’ grades was defined as
’effective treatment’ frequency. One day after treatment the per-
centage of ’effective treatment’ was 94% (15/16) in the laser group
and 48% (12/25) in the sham group (P = 0.007). The pain results
in intermediate-term (three months to one year) and long-term
follow-ups were not reported in any other studies.
In summary, five studies (238 people) showed significant pain
relief with LLLT in short term and intermediate term follow-ups.
Three of them used adequate dosing as defined byWALT-b 2005.
However, because of the small trials and the clinical heterogeneity
of the population, treatment and outcome measurements, there
are insufficient data to support or refute the efficacy of LLLT to
reduce pain for individuals with subacute or chronic LBP, when
compared to a sham treatment, with or without the addition of
exercises as co-interventions.
Disability:
Pain-related disability was measured using the Oswestry ques-
tionnaire (Basford 1999), Modified Oswestry questionnaire (Gur
2003) and a validated 24-item questionnaire (Klein 1990). The
pooled analysis of three trials (n = 126) failed to show a difference
in short-term disability measures between the LLLT and sham
groups, with a pooled SMD of -0.14 (95% CI: -0.88 to 0.59)
for patients with chronic low-back pain without neurologic symp-
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toms. Only one study (Basford 1999), showed a significant im-
provement in disability measures with a SMD of -0.81 (95% CI:
-1.36 to -0.26). It used an adequate dosing but a different type of
laser and included a slightly different population of low-back pain.
Gur 2003 and Klein 1990 used inadequate laser dosing, with a
SMD of 0.21 (95%CI: -0.26 to 0.68). The same results were seen
when the studies with exercise therapy as the co-intervention in
both study arms (Gur 2003; Klein 1990) were compared to the
study without exercise therapy (Basford 1999).
One study (Longo 1991) measured the overall efficacy of treat-
ment using the Ritchie scale, which includes improvement in pain,
functional deficit and analgesic deviation. These symptoms com-
pletely disappeared or improved in 97.5% of patients in the LLLT
group and 37.5% of the control group after one month.
In summary, four studies (278 people) measured disability. How-
ever, because of the small trials and the clinical heterogeneity of
the population, treatment and outcome measurements, there are
insufficient data to support or refute the efficacy of LLLT to reduce
disability in individuals with (sub)acute or chronic LBP, when
compared to a sham treatment, with or without the addition of
exercises as co-interventions.
Relapse rate:
The percentage of relapse was reported in two trials (Longo 1991;
Soriano 1998). In one trial (Longo 1991), the relapse rates were
reported after one month, six months and one year after the be-
ginning of the study. Soriano 1998 reported the relapse rate at
six months follow-up. Therefore, the pooled analysis (random-
effects) of two trials (n = 151) shows that LLLT is more effective
than sham for patients with (sub)acute or chronic low-back pain
without neurologic symptoms on relapse rate (intermediate-term
follow-up) with RR 0.43 (95%CI 0.28 to 0.65). Soriano 1998
used adequate laser dosage with a senior population with chronic
LBP and Longo 1991 used inadequate dosage, with a working-
aged population with acute LBP of undetermined duration. Both
studies showed significant difference in relapse rate at intermedi-
ate-term follow-up.
Secondary Outcomes:
Three studies (Basford 1999; Gur 2003; Klein 1990) measured
lumbar mobility. Two of them (Basford 1999; Gur 2003) assessed
the range of motion in centimetres using the Schober test (Moll
1971). The other one (Klein 1990) measured it in degrees using a
validated computerized isodynamic system. Because of the differ-
ence in the instruments the standardized mean difference was cal-
culated. The pooled analysis of three trials (n = 126) using a fixed-
effect method (because of the statistical homogeneity of results)
failed to show a difference in anterior-posterior lumbar range of
motion between the LLLT and control groups in short-term fol-
low-up with a SMD of 0.01 (95% CI:-0.34 to 0.36). Compar-
ing lumbar range of motion in short-term follow-up, one study
(Basford 1999) used adequate dosing, resulting in a SMD of -
0.05 (95% CI: -0.58 to 0.47), and two studies (Gur 2003; Klein
1990) used inadequate laser dosing, ending with a pooled SMD
of 0.07 (95%CI: -0.40 to 0.54). The same results were seen when
the studies with exercise therapy as a co-intervention in both study
arms (Gur 2003; Klein 1990) were compared with the study with-
out exercise therapy (Basford 1999).
However, as with other outcomes, because of the small trials and
the clinical heterogeneity of the population, treatment and out-
come measurements, there are insufficient data to support or re-
fute the efficacy of LLLT.
One study (Basford 1999) reported the perceptionof benefitwhich
was assessed using a visual analogue scale. At the one-month fol-
low-up, the difference in the mean of perception of benefit in the
laser and control groups was 9.5 mm (95% CI:-1.9 to 20.9).
Adverse effects:
Two studies reported neither discomfort related to laser treatment
nor an increase in pain in either group (Klein 1990; Toya 1994).
In Soriano 1998, five patients in the LLLT group (two abandoned
and three needed to use NSAIDS) and nine patients in the control
group (three abandoned and six needed to use NSAIDS) were lost
to follow-up.
Due to ambiguity and overlap of the definitions of the duration of
low-back pain, subgroup analyses for acute, sub-acute and chronic
low-back pain were not performed.
D I S C U S S I O N
The results for pain are based on five studies (Basford 1999; Gur
2003; Klein 1990; Soriano 1998; Toya 1994), three of which were
pooled and showed a statistically significant improvement in pain
relief after laser treatment in short-term and intermediate-term
follow-ups. All five studies had reasonable quality (met at least 6
criteria) and all except two (Longo 1991, Toya 1994) included
sub-acute or chronic non-specific low-back pain. Our findings
suggest that low level laser therapy can be beneficial for pain re-
lief in patients with chronic non-specific low-back pain. However,
this improvement (WMD -11.3 mm on visual analogue scale) is
less than the minimum clinically significant improvement (Farrar
2001). Therefore, when one considers this, along with the clinical
heterogeneity of the studies, which reduces the confidence we can
have in a pooled effect size, one is forced to question the efficacy
of LLLT to improve back-related symptoms, based on the current
literature. Other systematic reviews on the effects of LLLT on pain
showed similar small effects onpain relief. The systematic reviewof
the effectiveness of LLLT on rheumatoid arthritis (Brosseau 2006
A) suggested that LLLT was effective at reducing pain relative to
placebo (WMD -11 mm). Another systematic review investigat-
ing the effectiveness of LLLT on joint disorders (Bjordal 2003)
concluded that LLLT seemed to be effective in reducing pain due
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to chronic joint disorders (WMD -29.8 mm). A Cochrane review
on LLLT for osteoarthritis (Brosseau 2006 B) reported conflict-
ing results of different studies about the effectiveness of low level
lasers for pain. According to our findings, the pain relief effect of
LLLT was sustained up to intermediate-term follow-up in some
circumstances, as shown in the pain relapse rate findings. A possi-
ble explanation of the effects of LLLT on pain relief is its anti-in-
flammatory and connective tissue repair process which have been
shown in some in vitro and in vivo studies (Sakurai 2000; Sattayut
1999; Skinner 1996).
We could not find any statistically significant improvement in low-
back pain-related disability or range of motion after laser therapy.
It may be due to the use of very low laser doses in the studies,
which limits its efficacy. Only Basford 1999 study showed a sig-
nificant improvement in disability measures, which used a higher
laser dosage than other studies. Bjordal 2003 found that after ad-
justment for tissue penetration, many laser doses used in many
of the trials are too low to have any significant anti-inflammatory
effects at target locations. According to this limited evidence, it
seems that LLLT effects are clinically modest and could not sub-
stitute for other beneficial interventions such as exercise therapy.
The effectiveness of exercise and intensive multidisciplinary pain
treatment programmes for chronic low-back pain is supported by
strong evidence (Koes 2006).
LLLT may have some clinical effects on low-back pain in doses
less than the minimum recommended doses of the World Associ-
ation of Laser Therapy (WALT-b 2005). However, more research
is needed on the optimal dose, wavelength and number of treat-
ments before the recommendations could reasonably be changed.
No serious adverse events were reported in the trials included in
this review, but the total sample size of included trials was small
for judgment about the safety of this intervention.
Low power lasers are sometimes irradiated to acupuncture points
in addition to painful areas. The rationale for laser acupuncture
is vastly different from phototherapy. Instead of using the direct
effect of light on tissues to initiate a physiological response, in
laser acupuncture, the selection of points is based on a diagnostic
and therapeutic paradigm defined in acupuncture theories (Chow
2006). Therefore laser acupuncture studies were excluded from
the current review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Based on the current literature, we conclude that there are insuf-
ficient data to draw firm conclusions on the efficacy of LLLT to
reduce pain and disability in individuals with LBP. When infrared
wavelengths are used, LLLT appears to have a small effect on pain
intensity and frequency in patients suffering from chronic low-
back pain, if applied to painful areas for at least two weeks. But,
based on our findings, LLLT should not be substituted for other
beneficial interventions such as exercise therapy.
Implications for research
There is a need for further methodologically rigorous RCTs eval-
uating different lengths of treatment, different wavelengths and
different dosages. Comparison of different LLLT treatments will
be more reasonable if dose calculation methods are harmonized.
Cost-effectiveness studies are recommended.
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T A B L E S
Characteristics of included studies
Study Basford 1999
Methods Study design: RCT; Unit of allocation: Patients; Method of randomization: bloc randomized with a computer
generated schedule; Allocation concealment: inadequate; Blindedness: Double-masked
Participants Randomized = 63; Analysed = 59
Recruitment of patients: announcement in the institutional newsletter and the local newsletter and by referal
from local physicians; Enrollment dates: Not stated; Age: Between the ages of 18 and 70 years; Sex: Male
and female; Ethnicity: Not stated; Work status: Not stated; Diagnosis of LBP: Localized pain and tenderness
in the vicinity of the lumbosacral spine with normal neurologic examination results; Duration of pain:
More than 30 days; Previous treatments: No treatment of this problem by a physician, physical therapist,
chiropractor or health care provider in the previous 30 days. Analgesic and nonsteroidal antiinflammatory
medication use was not encouraged but wasmonitored as an experimental variable; Exclusion criteria: Surgery
(eg,fusion), Pending of litigation or workman’s compensation issues, Corticosteroids for any reason in the
last 30 days, Radicular pain(Described as pain extending below their bottoks, or noted changes in bowel or
bladder function or lower exterimity strenght or sensation.) Women were recruited to be postmenopausal or
practicing an effective means of birth control (pregnancy tests were obtained).
Interventions Both arms of the trial were included: LLLT(27) and sham(29).
Intervention group: laser, Three times a week, 4 week schedule by a masked therapist with the subjects
removing their shirt and lying prone on a plinth. The therapist scrubbed the lumbar paraspinal muscles with
an alcohol-soaked gauze pad; Laser medium:Nd-YAG; Laser model: Laser Biotherapy; Wave length(nm):
1060 nm; Lasermode: Continuous-wave;Output power: 1626mW; Spot diameter(cm): not stated; Exposure
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Characteristics of included studies (Continued )
time(seconds): 90 sec; Anatomic locations: At each of four equally spaced level (a total of 8 points) along the
L2 to S3 paraspinal tissues
Control group: Irradiated with the same, but inactive laser device
Outcomes Measurements by: An experienced and masked physician and therapist not involved in the treatment; mea-
sured variables: Function(Oswestry disability questionnaire, validated), pain( visual analog scale,validated),
lumbar mobility(a modification of the schober test), changes in medicatin use , activity level, perception of
benefit, pain nature, and any adverse effects from treatment; Follow up sessions: sixth session, twelfth session,
28 to 35 days after the last treatment; Intention-to-treat analysis: no
Notes Total score: 8
Allocation concealment C – Inadequate
Study Gur 2003
Methods Study design: RCT; Unit of allocation: Patients; Method of randomization: Not stated; Allocation conceal-
ment: not used; Blindedness: Single blind
Participants n = 75;
Recruitment of patients: not stated; Enrollment dates: May 1999 and March 2000; Age: Between the ages
of 20 and 50 years; Sex: Male and female; Ethnicity: Not stated; Work status: Not stated; Diagnosis of LBP:
self-reported criteria plus information concerning the existence of medical conditions, medication use and
the possibility of serious injuries.; Duration of pain: More than one year; Previous treatments: No previous
spinal surgery; Exclusion criteria: neurological deficits, abnormal laboratory findings, systemic and psychiatric
illnesses, pregnancy
Interventions Two arms of the study were included: LLLT+exercise(25) and sham+exercise(25)
Intervention group: laser+exercise, five times a week , 4 weeks; Laser medium:Gallium-Arsenide laser; Laser
model: Frank Line IR 30, Fysiomed, Belgium; Wave length(nm): Not stated; Laser mode: Pulsed, 2.1
kHz pulse frequency; Output power: 10W, 4.2mW average power; Laser class: IIIb; Spot diameter(cm):
1.1cm; Exposure time(seconds): 4 min; Anatomic locations: the L4 to L5 and L5 to S1 apophyseal capsules,
dorsolumbar fascia, and interspinous ligaments, as well as the gluteal fascia, posterior sacroiliac ligaments,
hamstrings, and gastro-soleus muscles of which pain points were palpated from the low back to the foot
Control group: exercise therapy: lumbar flexion and extension, knee flexion, hip adduction exercises, and
strength exercises of extremity muscle groups/ first session of the exercises was conducted with a physiother-
apist and continued at home by the patients themselves. two sessions a day, making a total of 40 sessions for
4 weeks
Outcomes Measurements by: A physician who didn’t know which therapy was taken evaluated the patients; Measured
variables: Functioning(Roland Disability Questionnaire (RDQ) and Modified Oswestry Disability Ques-
tionnaire (MODQ)), Pain( visual analogue scale (VAS)), Lumbar range of motion( Schober test), flexion
and lateral flexion measures; Follow up sessions: one month after therapy; Intention-to-treat analysis: no
Notes Total score: 6
Allocation concealment B – Unclear
Study Klein 1990
Methods Study design: RCT; Unit of allocation: Patients; Method of randomization: a computer generated random
numbers table; Allocation concealment: yes; Blindedness: yes
Participants n= 20
Recruitment of patients: By advertisement; Enrollment dates: Not stated; Age: Between the ages of 21 and
55 years; Sex: Male and female; Ethnicity: Not stated; Work status: Not stated; Diagnosis of LBP: Clinical
features of back pain with prolonged maintenance of one posture, such as prolonged sitting, standing, or
bending and temporary relief of symptoms witrh changing positions or walking; Duration of pain: More than
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Characteristics of included studies (Continued )
one year; Previous treatments: No prior back surgery; Exclusion criteria: Acute exacerbation of chronic LBP,
not pregnant, no prior surgery, not >10 pounds overweight, not involved in litigation or disability claims
Interventions Both arms of the trial were included: LLLT+exercise(10) and sham+exercise(10).
Intervention group: laser+exercise, three times a week , 4 weeks; Laser medium:Ga-As laser; Laser model:
Omniprobe (laser biostimulation unit); Wave length(nm): 904nm; Laser mode: Pulsed, 1 kHz pulse fre-
quency, 200 nsec pulse duration; Output power: 2W; Laser class: I; Spot diameter(cm): 1.1cm in each head
with 10 heads; Exposure time(seconds): 240sec (4min) for each point [20 min of total stimulation time for
each patient]; Anatomic locations: external over a series of standardized fields designed to include the L4
to L5 & L5 to S1 apophyseal capsules, dorsolumbar fascia, interspinous ligaments, gluteal fascia, posterior
sacroiliac ligaments
Control group: Home Exercise program: 50 full-forward flexion exercises performed in standing position
followed by 25 extension exercises twice a day, walk briskly: 20 min a day, 2 sets of knee flexion coupled with
hip abduction each day. Exercises were to be started on the first day of the study and countinuoud at least
untill completion of all objective and subjective measurements.
Outcomes Measurements by: a blinded physical therapist ; Measured variables: Disability score( a questionnaire of 24
items(validated)), Pain(VAS(0-7.5cm)), Lumbar function (range of motion/ isometric torque/ isodynamic
velocities), the isotechnologies B100(a commercially available computerized isodynamic system)/ (validated);
Follow up sessions: one month after therapy; Intention-to-treat analysis: yes
Notes Total score: 11
Allocation concealment A – Adequate
Study Longo 1991
Methods Study design: RCT; Unit of allocation: Patients; Method of randomization: Not stated; Allocation conceal-
ment:unclear; Blindedness: yes
Participants n = 120 (40 to each of 3 groups), but only used 2 groups in this review, therefore n = 80
Recruitment of patients: Not stated; Enrollment dates: Not stated; Age: Between the ages of 40 and 65 years;
Sex: Male and female; Ethnicity: Not stated; Work status: Not stated; Diagnosis of LBP: acute lumbago with
degenerative or traumatic lesions visible in X-ray and without obvious signs of neurologic deficit ; Duration
of pain: acute(?); Previous treatments: No previous therapy which interfers with the results of the experiment
; Exclusion criteria: Fracture, luxation, hernia of the nucleus pulposus
Interventions Two arms of the trial were included: LLLT(40) and sham(40).
Intervention group: laser, Treatment begun within 24hr of the onset of the symptoms once a day for
5 days,then another 5 on alternative days; Laser medium:Diode laser ; Laser model: Not stated; Wave
length(nm): 904nm; Laser mode: Pulsed, 3 kHz pulse frequency, 200 nsec pulse duration; Output power:
peak power 72W (27W?); Laser class: Not stated; Spot diameter(cm): 0.2 cm(1 cm2 spot area using lens cor-
rection); Exposure time(seconds): 5min/cm2 (of every radiation); Anatomic locations: Intervertebral holes,
possible trigger points
Control group: simulated laser irradiation
Outcomes Measurements by: two blinded doctors; Measured variables: spontenous or induced pain( Ritchie scale for
intensity of pain), level of reflected analgesic vertebral deviation(the angel of inclination in an AP X-ray
(validation not mentioned)), functional limitation (percentage of normal movement of the sacral-lumbar area
(validation not mentioned)); Follow up sessions: after 3 applications, after 5 applications, after one month,
after six months, after one year; Intention-to-treat analysis: no
Notes Total score: 7
Allocation concealment B – Unclear
Study Soriano 1998
Methods Study design: RCT; Unit of allocation: Patients; Method of randomization: Not stated; Allocation conceal-
ment: no; Blindedness: yes
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Characteristics of included studies (Continued )
Participants randomized = 85; analyzed = 71 (5/43 dropped out from experimental group; 9/42 dropped out from control
group)
Recruitment of patients: Not stated; Enrollment dates: Not stated; Age: more than 60 years; Sex: Male and
female; Ethnicity: Not stated; Work status: Not stated; Diagnosis of LBP: Not stated ; Duration of pain: >3
months; Previous treatments: The use of analgesic drugs and physical therapy was excluded in both groups, a
wash-out period of 5 days was done on any patient on NSAIDs; Exclusion criteria: any suspicious of cancer,
any suspicious of osteomyelitis, any suspicious of gout, any suspicious of paget’s disease, any suspicious of
collagen disease, symptoms or signs of neurologic deficits in the lower limbs, usage of long acting corticoids
within the prior 30 days
Interventions Both arms of the trial were included: LLLT(38) and sham(33).
Intervention group: laser, five sessions a week for 2 weeks; Laser medium:Ga-As diode laser ; Laser model:
Not stated; Wave length(nm): 904nm; Laser mode: Pulsed, 10 kHz pulse frequency, 200 nsec pulse duration;
Output power: peak power 20W, average power:40 mW; Laser class: Not stated; Spot diameter(cm): 1.1cm?;
Exposure time(seconds): 100; Anatomic locations: On painful area
Control group: Sham irradiation with a deactivated laser radiation, but the electrical circuit, timer and alarm
worked as usual so that to all intents and purposes it was exactly identical to the real system.
Outcomes Measurements by: Not stated;Measured variables: pain(VAS), Radiologic findings (osteopoenia, osteophytes,
narrowing of disc spaces, spondylolisthesis grade 1), physical examination; Follow up sessions: every 1month
for six months; Intention-to-treat analysis: no
Notes Total score: 6
Allocation concealment B – Unclear
Study Toya 1994
Methods Study design: RCT; Unit of allocation: Patients; Method of randomization: a computer generated schedule;
Allocation concealment: adequate; Blindedness: Double-blinded
Participants randomized = 130; analyzed 115, 41 of whom had LBP and were included in this review
Recruitment of patients: patients attending their respective institution on an outpatient basis; Enrollment
dates: Not stated; between the ages of 18 to 82y; Sex:Male and female; Ethnicity:Not stated;Work status:Not
stated; Diagnosis of LBP: Not stated, Lumbar pain group(41 patients) consisted of Lumbago(23), Ischiatic
neuralgia(9), Lumbar musculofascial pain(2), herniated disc(3), lumbar spondylosis(4); Duration of pain:
not stated; Previous treatments: no limitations, a wash-out period was done on any patient on medications;
Exclusion criteria: not stated
Interventions Both arms of the trial were included: LLLT(16) and sham(25).
Intervention group: laser, single session, no other treatments allowed; Laser medium:Ga-Al-As diode laser ;
Laser model: OhLase-3D1(Proli, Japan);Wave length(nm): 830nm; Laser mode: continuous; Output power:
60 mW; Laser class: Not stated; Spot diameter(cm): 0.16cm; Exposure time(seconds): 5 to 10 min (mean of
9.18 min); Anatomic locations: On painful area
Control group: Sham irradiation with a deactivated laser radiation, but the electrical circuit, timer and alarm
worked as usual and controlled by a locked remote centralised computer
Outcomes Measurements by: a blinded therapist ; Measured variables: pain graded as exacerbation, little or no change,
fair, good, excellent; Follow up sessions: immediately and one day after treatment; Intention-to-treat analysis:
no
Notes Total score: 9
Allocation concealment A – Adequate
14Low level laser therapy for nonspecific low-back pain (Review)
Copyright © 2007 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Characteristics of excluded studies
Study Reason for exclusion
Bertocco 2002 No LLLT group
Gale 2006 no LLLT group. Infrared therapy
Gallacchi 1981 no clinically important outcomes reported.
Georgiev 1996 Radiculopathy, low-back pain caused by specific pathological entities
Grabowski 1981 Not RCT or CCT
Gurtler 1979 Not RCT or CCT
Kou 1991 Laser acupuncture
Kreczi 1986 No separate analysis for Low back pain
Mika 1990 Not RCT or CCT
Ohshiro 1992 Not RCT or CCT
Okamoto 1989 No separate analysis for Low back pain
Pashnev 1991 Radiculopathy, low-back pain caused by specific pathological entities. No separate analysis for Low back pain
Snyder 1986 No separate analysis for Low back pain
Snyder 1989 No separate analysis for Low back pain
Tasaki 1991 Not RCT or CCT
Zati 2004 High power laser, Disc displacement
A D D I T I O N A L T A B L E S
Table 01. Search strategy for MEDLINE & CINAHL
1.randomized controlled trial.pt.
2.controlled clinical trial.pt
3.Randomized Controlled Trials/
4.Random Allocation/
5.Double-Blind Method/
6.Single-Blind Method/
7.or/1-6
8.Animal/ not Human/
9.7 not 8
10.clinical trial.pt.
11.exp Clinical Trials/
12.(clin$ adj25 trial$).tw.
13.((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.
14.Placebos/
15.placebo$.tw.
16.random$.tw.
17.Research Design/
18.(latin adj square).tw.
19. or/10-18
20.19 not 18
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Table 01. Search strategy for MEDLINE & CINAHL (Continued )
21.20 not 9
22.Comparative Study/
23.exp Evaluation Studies/
24.Follow-Up Studies/
25.Prospective Studies?
26.(control$ or prospective$ or Volunteer$).tw.
27.Cross-Over Studies/
28.or/22-27
29.28 not 8
30.29 not (9 or 21)
31.9 or 21 or 30
32. back pain.sh
33. low back pain.sh
34. back pain.ti,ab
35. backache.ti,ab
36. exp back pain/
37. dorsalgia.ti,ab
38. lumbago.ti,ab
39. (lumbar adj pain).ti,ab
40.or/32-39
41. laser$.sh
42. laser$.tw
43. exp light/
44. infrared.tw
45. ultraviolet.tw
46. monochromatic.tw
47.or/41-46
48.31 and 40 and 47
Table 02. Criteria for internal validity
Criteria
A Was the method of randomization adequate? A random (unpredictable) assignment sequence.
B Was the treatment allocation concealed? Assignment generated by an independent person not responsible for determining the
eligibility of the patients. This person has no information about the persons included in the trial and has no influence on the
assignment sequence or on the decision about eligibility of the patient.
C Were the groups similar at baseline regarding the most important prognostic indicators? In order to receive a “yes”, groups have to
be similar at baseline characteristics.
D Was the patient blinded to the intervention? The reviewer determines if enough information about the blinding is given in order to
score a “yes.”
E Was the care provider blinded to the intervention? The reviewer determines if enough information about the blinding is given in
order to score a “yes.”
F Was the outcome assessor blinded to the intervention? The reviewer determines if enough information about the blinding is given
in order to score a “yes.”
GWere co-interventions avoided or similar? Co-interventions should either be avoided in the trial design or similar between the index
and control groups.
H Was the compliance acceptable in all groups? The reviewer determines if the compliance to the interventions is acceptable.
I Was the drop-out rate described and acceptable? The number of participants who were included in the study but did not complete
the observation period or were not included in the analysis must be described and reasons given. If the percentage of withdrawals and
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Table 02. Criteria for internal validity (Continued )
Criteria
drop-outs does not exceed 20% for short-term follow-up and 30% for long-term follow-up and does not lead to substantial bias a
“yes” is scored.
J Was the timing of the outcome assessment in all groups similar? Timing of outcome assessment should be identical for all
intervention groups and for all important outcome assessments.
K Did the analysis include an intention-to-treat analysis? All randomized patients are reported/analyzed in the group they were
allocated to by randomization for the most important moments of effect measurement (minus missing values) irrespective of
noncompliance and co-interventions.
Table 03. Quality assessment of included studies
Name of
study
Randomi-
sation
Conc. of
allocation
Baseline
assess-
ments Blinding
Co-inter-
vention
Compli-
ance
Drop-out
rates
Outcome
assess-
ment
Total
score
Basford
1999
Adequate No No Patients,
providers,
assessors
Avoided Acceptable Acceptable similar
timing: +;
intention-
to-treat: -
8
Gur 2003 inadequate
informa-
tion
No Yes assessors Avoided Acceptable Acceptable similar
timing: +;
intention-
to-treat: -
6
Klein
1990
Adequate Yes Yes Patients,
providers,
assessors
Avoided Acceptable Acceptable similar
timing: +;
intention-
to-treat: +
11
Longo
1991
inadequate
informa-
tion
Unclear Unclear Patients,
providers,
assessors
Avoided Acceptable Acceptable similar
timing: +;
intention-
to-treat: -
7
Soriano
1998
inadequate
informa-
tion
No Yes Patients,
providers
Avoided Acceptable More than
20% in
Control
group
similar
timing: +;
intention-
to-treat: -
6
Toya 1994 Adequate Yes Unclear Patients,
providers,
assessors
Avoided Acceptable Acceptable similar
timing: +;
intention-
to-treat: -
9
Table 04. Laser dosing and characteristics of included studies
Name of
study
Laser
medium
Wave length
(nm) Laser mode
Output
power
Power
density
Dose
(J/point)
Adequacy
(WALT)
Basford 1999 Nd-YAG 1060 Continuous 1626 mW 542 mW/cm2 48.8J Yes
Gur 2003 Gallium- Not stated Pulsed, 2.1 peak power 4.4 mW/cm2 1 J No
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Table 04. Laser dosing and characteristics of included studies (Continued )
Name of
study
Laser
medium
Wave length
(nm) Laser mode
Output
power
Power
density
Dose
(J/point)
Adequacy
(WALT)
Arsenide kHz pulse
frequency
10W
Klein 1990 Gallium-
Arsenide
904 Pulsed, 1
kHz pulse
frequency,
200 nsec
pulse duration
peak power
2W
0.4 mW/cm2 0.1 J No
Longo 1991 Gallium-
Arsenide
904 Pulsed, 3
kHz pulse
frequency,
200 nsec
pulse duration
peak power
72W (27W?)
10 mW/cm2 3 J No
Soriano 1998 Gallium-
Arsenide
904 Pulsed, 10
kHz pulse
frequency,
200 nsec
pulse duration
peak power
20W
40 mW/cm2 4 J Yes
Toya 1994 Ga-Al-As 830 continuous 60 mW 3000
mW/cm2
18-36 J Yes
A N A L Y S E S
Comparison 01. LLLT versus sham intervention (grouping based on follow-up durations)
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Pain (VAS) 3 126 Weighted Mean Difference (Fixed) 95% CI -11.33 [-16.91, -
5.75]
02 Low back pain related disability 3 126 Standardised Mean Difference (Random) 95%
CI
-0.14 [-0.88, 0.59]
03 Range of motion (Anterior-
posterior flexion)
3 126 Standardised Mean Difference (Fixed) 95% CI 0.01 [-0.34, 0.36]
05 Relapse Relative Risk (Random) 95% CI Subtotals only
Comparison 02. LLLT versus sham intervention (grouping based on laser dosing)
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Pain(VAS)-short term follow-
up
3 126 Weighted Mean Difference (Fixed) 95% CI -11.33 [-16.91, -
5.75]
02 Low back pain related
disability-Short term follow-up
3 126 Standardised Mean Difference (Random) 95%
CI
-0.14 [-0.88, 0.59]
03 Range of motion-short term
follow-up
3 126 Standardised Mean Difference (Fixed) 95% CI 0.01 [-0.34, 0.36]
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04 Relapse-Intermediate term
follow-up
2 151 Relative Risk (Random) 95% CI 0.43 [0.28, 0.65]
Comparison 03. LLLT versus sham intervention (grouping based on the presence of exercise therapy)
Outcome title
No. of
studies
No. of
participants Statistical method Effect size
01 Pain (VAS) 3 126 Weighted Mean Difference (Fixed) 95% CI -11.33 [-16.91, -
5.75]
02 Low back pain related disability 3 126 Standardised Mean Difference (Random) 95%
CI
-0.14 [-0.88, 0.59]
03 Range of motion ( Anterior-
posterior flexion)
3 126 Standardised Mean Difference (Fixed) 95% CI 0.01 [-0.34, 0.36]
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G R A P H S A N D O T H E R T A B L E S
Analysis 01.01. Comparison 01 LLLT versus sham intervention (grouping based on follow-up durations),
Outcome 01 Pain (VAS)
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 01 LLLT versus sham intervention (grouping based on follow-up durations)
Outcome: 01 Pain (VAS)
Study LLLT Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Short term follow up (less than 3 months after randomization)
Basford 1999 27 19.10 (22.80) 29 35.10 (22.80) 21.8 -16.00 [ -27.95, -4.05 ]
Gur 2003 25 18.00 (12.00) 25 29.00 (13.00) 64.8 -11.00 [ -17.94, -4.06 ]
Klein 1990 10 22.66 (18.66) 10 28.00 (16.00) 13.4 -5.34 [ -20.57, 9.89 ]
Subtotal (95% CI) 62 64 100.0 -11.33 [ -16.91, -5.75 ]
Test for heterogeneity chi-square=1.19 df=2 p=0.55 I² =0.0%
Test for overall effect z=3.98 p=0.00007
02 Intermediate-term follow up (3 months to 1 year)
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
-100.0 -50.0 0 50.0 100.0
Favours LLLT Favours sham (Continued . . . )
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(. . . Continued)
Study LLLT Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
03 Long-term follow up (longer than one year)
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 62 64 100.0 -11.33 [ -16.91, -5.75 ]
Test for heterogeneity chi-square=1.19 df=2 p=0.55 I² =0.0%
Test for overall effect z=3.98 p=0.00007
-100.0 -50.0 0 50.0 100.0
Favours LLLT Favours sham
Analysis 01.02. Comparison 01 LLLT versus sham intervention (grouping based on follow-up durations),
Outcome 02 Low back pain related disability
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 01 LLLT versus sham intervention (grouping based on follow-up durations)
Outcome: 02 Low back pain related disability
Study LLLT Control Standardised Mean Difference (Random) Weight Standardised Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Short term follow up (less than 3 months after randomization)
Basford 1999 27 14.70 (10.00) 29 22.90 (10.00) 36.4 -0.81 [ -1.36, -0.26 ]
Gur 2003 25 14.80 (8.60) 25 13.60 (7.20) 36.2 0.15 [ -0.41, 0.70 ]
Klein 1990 10 3.60 (2.10) 10 2.90 (1.60) 27.4 0.36 [ -0.53, 1.24 ]
Subtotal (95% CI) 62 64 100.0 -0.14 [ -0.88, 0.59 ]
Test for heterogeneity chi-square=7.79 df=2 p=0.02 I² =74.3%
Test for overall effect z=0.38 p=0.7
02 Intermediate-term follow up (3 months to 1 year)
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
03 Long-term follow up (longer than one year)
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 62 64 100.0 -0.14 [ -0.88, 0.59 ]
Test for heterogeneity chi-square=7.79 df=2 p=0.02 I² =74.3%
Test for overall effect z=0.38 p=0.7
-10.0 -5.0 0 5.0 10.0
Favours LLLT Favours sham
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Analysis 01.03. Comparison 01 LLLT versus sham intervention (grouping based on follow-up durations),
Outcome 03 Range of motion (Anterior-posterior flexion)
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 01 LLLT versus sham intervention (grouping based on follow-up durations)
Outcome: 03 Range of motion (Anterior-posterior flexion)
Study LLLT Control Standardised Mean Difference (Fixed) Weight Standardised Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Short term follow up (less than 3 months after randomization)
Basford 1999 27 14.00 (3.70) 29 14.20 (3.70) 44.6 -0.05 [ -0.58, 0.47 ]
Gur 2003 25 18.30 (3.60) 25 18.50 (3.40) 39.8 -0.06 [ -0.61, 0.50 ]
Klein 1990 10 56.70 (4.80) 10 53.40 (10.40) 15.6 0.39 [ -0.50, 1.28 ]
Subtotal (95% CI) 62 64 100.0 0.01 [ -0.34, 0.36 ]
Test for heterogeneity chi-square=0.82 df=2 p=0.66 I² =0.0%
Test for overall effect z=0.08 p=0.9
02 Intermediate-term follow up (3 months to 1 year)
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
03 Long-term follow up (longer than one year)
Subtotal (95% CI) 0 0 0.0 Not estimable
Test for heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 62 64 100.0 0.01 [ -0.34, 0.36 ]
Test for heterogeneity chi-square=0.82 df=2 p=0.66 I² =0.0%
Test for overall effect z=0.08 p=0.9
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Analysis 01.05. Comparison 01 LLLT versus sham intervention (grouping based on follow-up durations),
Outcome 05 Relapse
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 01 LLLT versus sham intervention (grouping based on follow-up durations)
Outcome: 05 Relapse
Study LLLT Control Relative Risk (Random) Weight Relative Risk (Random)
n/N n/N 95% CI (%) 95% CI
01 Short term follow up (less than 3 months after randomization)
Longo 1991 0/40 5/40 100.0 0.09 [ 0.01, 1.59 ]
Subtotal (95% CI) 40 40 100.0 0.09 [ 0.01, 1.59 ]
Total events: 0 (LLLT), 5 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=1.64 p=0.1
02 Intermediate-term follow up (3 months to 1 year)
Longo 1991 12/40 35/40 49.0 0.34 [ 0.21, 0.56 ]
Soriano 1998 14/38 23/33 51.0 0.53 [ 0.33, 0.85 ]
Subtotal (95% CI) 78 73 100.0 0.43 [ 0.28, 0.65 ]
Total events: 26 (LLLT), 58 (Control)
Test for heterogeneity chi-square=1.57 df=1 p=0.21 I² =36.5%
Test for overall effect z=3.91 p=0.00009
03 Long-term follow up (longer than one year)
Longo 1991 26/40 38/40 100.0 0.68 [ 0.54, 0.87 ]
Subtotal (95% CI) 40 40 100.0 0.68 [ 0.54, 0.87 ]
Total events: 26 (LLLT), 38 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=3.12 p=0.002
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Analysis 02.01. Comparison 02 LLLT versus sham intervention (grouping based on laser dosing), Outcome 01
Pain(VAS)-short term follow-up
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 02 LLLT versus sham intervention (grouping based on laser dosing)
Outcome: 01 Pain(VAS)-short term follow-up
Study LLLT Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Adequate dosing
Basford 1999 27 19.10 (22.80) 29 35.10 (22.80) 21.8 -16.00 [ -27.95, -4.05 ]
Subtotal (95% CI) 27 29 21.8 -16.00 [ -27.95, -4.05 ]
Test for heterogeneity: not applicable
Test for overall effect z=2.62 p=0.009
02 Inadequate dosing
Gur 2003 25 18.00 (12.00) 25 29.00 (13.00) 64.8 -11.00 [ -17.94, -4.06 ]
Klein 1990 10 22.66 (18.66) 10 28.00 (16.00) 13.4 -5.34 [ -20.57, 9.89 ]
Subtotal (95% CI) 35 35 78.2 -10.03 [ -16.34, -3.72 ]
Test for heterogeneity chi-square=0.44 df=1 p=0.51 I² =0.0%
Test for overall effect z=3.11 p=0.002
Total (95% CI) 62 64 100.0 -11.33 [ -16.91, -5.75 ]
Test for heterogeneity chi-square=1.19 df=2 p=0.55 I² =0.0%
Test for overall effect z=3.98 p=0.00007
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Analysis 02.02. Comparison 02 LLLT versus sham intervention (grouping based on laser dosing), Outcome 02
Low back pain related disability-Short term follow-up
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 02 LLLT versus sham intervention (grouping based on laser dosing)
Outcome: 02 Low back pain related disability-Short term follow-up
Study LLLT Control Standardised Mean Difference (Random) Weight Standardised Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Adequate dosing
Basford 1999 27 14.70 (10.00) 29 22.90 (10.00) 36.4 -0.81 [ -1.36, -0.26 ]
Subtotal (95% CI) 27 29 36.4 -0.81 [ -1.36, -0.26 ]
Test for heterogeneity: not applicable
Test for overall effect z=2.90 p=0.004
02 Inadequate dosing
Gur 2003 25 14.80 (8.60) 25 13.60 (7.20) 36.2 0.15 [ -0.41, 0.70 ]
Klein 1990 10 3.60 (2.10) 10 2.90 (1.60) 27.4 0.36 [ -0.53, 1.24 ]
Subtotal (95% CI) 35 35 63.6 0.21 [ -0.26, 0.68 ]
Test for heterogeneity chi-square=0.16 df=1 p=0.69 I² =0.0%
Test for overall effect z=0.87 p=0.4
Total (95% CI) 62 64 100.0 -0.14 [ -0.88, 0.59 ]
Test for heterogeneity chi-square=7.79 df=2 p=0.02 I² =74.3%
Test for overall effect z=0.38 p=0.7
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Analysis 02.03. Comparison 02 LLLT versus sham intervention (grouping based on laser dosing), Outcome 03
Range of motion-short term follow-up
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 02 LLLT versus sham intervention (grouping based on laser dosing)
Outcome: 03 Range of motion-short term follow-up
Study LLLT Control Standardised Mean Difference (Fixed) Weight Standardised Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 Adequate dosing
Basford 1999 27 14.00 (3.70) 29 14.20 (3.70) 44.6 -0.05 [ -0.58, 0.47 ]
Subtotal (95% CI) 27 29 44.6 -0.05 [ -0.58, 0.47 ]
Test for heterogeneity: not applicable
Test for overall effect z=0.20 p=0.8
02 Inadequate dosing
Gur 2003 25 18.30 (3.60) 25 18.50 (3.40) 39.8 -0.06 [ -0.61, 0.50 ]
Klein 1990 10 56.70 (4.80) 10 53.40 (10.40) 15.6 0.39 [ -0.50, 1.28 ]
Subtotal (95% CI) 35 35 55.4 0.07 [ -0.40, 0.54 ]
Test for heterogeneity chi-square=0.70 df=1 p=0.40 I² =0.0%
Test for overall effect z=0.29 p=0.8
Total (95% CI) 62 64 100.0 0.01 [ -0.34, 0.36 ]
Test for heterogeneity chi-square=0.82 df=2 p=0.66 I² =0.0%
Test for overall effect z=0.08 p=0.9
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Analysis 02.04. Comparison 02 LLLT versus sham intervention (grouping based on laser dosing), Outcome 04
Relapse-Intermediate term follow-up
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 02 LLLT versus sham intervention (grouping based on laser dosing)
Outcome: 04 Relapse-Intermediate term follow-up
Study LLLT Control Relative Risk (Random) Weight Relative Risk (Random)
n/N n/N 95% CI (%) 95% CI
01 Adequate dosing
Soriano 1998 14/38 23/33 51.0 0.53 [ 0.33, 0.85 ]
Subtotal (95% CI) 38 33 51.0 0.53 [ 0.33, 0.85 ]
Total events: 14 (LLLT), 23 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=2.64 p=0.008
02 Inadequate dosing
Longo 1991 12/40 35/40 49.0 0.34 [ 0.21, 0.56 ]
Subtotal (95% CI) 40 40 49.0 0.34 [ 0.21, 0.56 ]
Total events: 12 (LLLT), 35 (Control)
Test for heterogeneity: not applicable
Test for overall effect z=4.30 p=0.00002
Total (95% CI) 78 73 100.0 0.43 [ 0.28, 0.65 ]
Total events: 26 (LLLT), 58 (Control)
Test for heterogeneity chi-square=1.57 df=1 p=0.21 I² =36.5%
Test for overall effect z=3.91 p=0.00009
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Analysis 03.01. Comparison 03 LLLT versus sham intervention (grouping based on the presence of exercise
therapy), Outcome 01 Pain (VAS)
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 03 LLLT versus sham intervention (grouping based on the presence of exercise therapy)
Outcome: 01 Pain (VAS)
Study LLLT Control Weighted Mean Difference (Fixed) Weight Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 LLLT + exercise versus sham + exercise
Gur 2003 25 18.00 (12.00) 25 29.00 (13.00) 64.8 -11.00 [ -17.94, -4.06 ]
Klein 1990 10 22.66 (18.66) 10 28.00 (16.00) 13.4 -5.34 [ -20.57, 9.89 ]
Subtotal (95% CI) 35 35 78.2 -10.03 [ -16.34, -3.72 ]
Test for heterogeneity chi-square=0.44 df=1 p=0.51 I² =0.0%
Test for overall effect z=3.11 p=0.002
02 LLLT versus sham
Basford 1999 27 19.10 (22.80) 29 35.10 (22.80) 21.8 -16.00 [ -27.95, -4.05 ]
Subtotal (95% CI) 27 29 21.8 -16.00 [ -27.95, -4.05 ]
Test for heterogeneity: not applicable
Test for overall effect z=2.62 p=0.009
Total (95% CI) 62 64 100.0 -11.33 [ -16.91, -5.75 ]
Test for heterogeneity chi-square=1.19 df=2 p=0.55 I² =0.0%
Test for overall effect z=3.98 p=0.00007
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Analysis 03.02. Comparison 03 LLLT versus sham intervention (grouping based on the presence of exercise
therapy), Outcome 02 Low back pain related disability
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 03 LLLT versus sham intervention (grouping based on the presence of exercise therapy)
Outcome: 02 Low back pain related disability
Study LLLT Control Standardised Mean Difference (Random) Weight Standardised Mean Difference (Random)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 LLLT + exercise vesus sham + exercise
Gur 2003 25 14.80 (8.60) 25 13.60 (7.20) 36.2 0.15 [ -0.41, 0.70 ]
Klein 1990 10 3.60 (2.10) 10 2.90 (1.60) 27.4 0.36 [ -0.53, 1.24 ]
Subtotal (95% CI) 35 35 63.6 0.21 [ -0.26, 0.68 ]
Test for heterogeneity chi-square=0.16 df=1 p=0.69 I² =0.0%
Test for overall effect z=0.87 p=0.4
02 LLLT versus sham
Basford 1999 27 14.70 (10.00) 29 22.90 (10.00) 36.4 -0.81 [ -1.36, -0.26 ]
Subtotal (95% CI) 27 29 36.4 -0.81 [ -1.36, -0.26 ]
Test for heterogeneity: not applicable
Test for overall effect z=2.90 p=0.004
Total (95% CI) 62 64 100.0 -0.14 [ -0.88, 0.59 ]
Test for heterogeneity chi-square=7.79 df=2 p=0.02 I² =74.3%
Test for overall effect z=0.38 p=0.7
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Analysis 03.03. Comparison 03 LLLT versus sham intervention (grouping based on the presence of exercise
therapy), Outcome 03 Range of motion ( Anterior-posterior flexion)
Review: Low level laser therapy for nonspecific low-back pain
Comparison: 03 LLLT versus sham intervention (grouping based on the presence of exercise therapy)
Outcome: 03 Range of motion ( Anterior-posterior flexion)
Study LLLT Control Standardised Mean Difference (Fixed) Weight Standardised Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI (%) 95% CI
01 LLLT + exercise versus sham + exercise
Gur 2003 25 18.30 (3.60) 25 18.50 (3.40) 39.8 -0.06 [ -0.61, 0.50 ]
Klein 1990 10 56.70 (4.80) 10 53.40 (10.40) 15.6 0.39 [ -0.50, 1.28 ]
Subtotal (95% CI) 35 35 55.4 0.07 [ -0.40, 0.54 ]
Test for heterogeneity chi-square=0.70 df=1 p=0.40 I² =0.0%
Test for overall effect z=0.29 p=0.8
02 LLLT versus sham
Basford 1999 27 14.00 (3.70) 29 14.20 (3.70) 44.6 -0.05 [ -0.58, 0.47 ]
Subtotal (95% CI) 27 29 44.6 -0.05 [ -0.58, 0.47 ]
Test for heterogeneity: not applicable
Test for overall effect z=0.20 p=0.8
Total (95% CI) 62 64 100.0 0.01 [ -0.34, 0.36 ]
Test for heterogeneity chi-square=0.82 df=2 p=0.66 I² =0.0%
Test for overall effect z=0.08 p=0.9
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